Healthy Living Europe
SEE OTHER BRANDS

Keeping up with healthcare and wellness news from Europe

Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on April 14, 2025

 Valneva reçoit la première autorisation de mise sur le marché pour IXCHIQ® dans un pays où le chikungunya est endémique

Valneva reçoit la première autorisation de mise sur le marché pour IXCHIQ® dans un pays où le chikungunya est endémique

Saint Herblain (France), le 14 avril 2025 - Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que l'agence de santé brésilienne (ANVISA) a accordé l'autorisation de mise sur le marché à son …

Prostadine Drops Reviews [We Tested It] Read Ingredients, Side Effects for Urinary System

Prostadine Drops Reviews [We Tested It] Read Ingredients, Side Effects for Urinary System

ST. PETERSBURG, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- Prostadine The Natural Solution for Prostate Health - As men age, prostate health often becomes a significant concern. The prostate, a small, walnut-sized gland in the male reproductive system, plays …

Johnson & Johnson’s Oral IL-23, Icotrokinra, Poised to Redefine the Psoriasis Treatment Landscape Following Positive Phase 3 Data, According to Spherix Global Insights

Johnson & Johnson’s Oral IL-23, Icotrokinra, Poised to Redefine the Psoriasis Treatment Landscape Following Positive Phase 3 Data, According to Spherix Global Insights

EXTON, PA, April 14, 2025 (GLOBE NEWSWIRE) -- Johnson …

[Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US

[Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules – corrected: reference to date of product launch in Europe removed; link to “Important Safety Information” updated Company aims to accelerate access to much-needed biosimilar to …

New Mindfulness App ‘Begin’ Launches, Bringing Calm to Pets and Their Owners

New Mindfulness App ‘Begin’ Launches, Bringing Calm to Pets and Their Owners

Magikbee, expands digital wellness to four-legged family members with Begin — a mindfulness app with guided exercises and calm sounds for the whole household. BRAGA, PORTUGAL, April 13, 2025 /⁨EINPresswire.com⁩/ -- A first-of-its-kind mindfulness app is …

Positron Corporation Secures Agreement to  Sell Four PET-CT Scanners

Positron Corporation Secures Agreement to Sell Four PET-CT Scanners

Niagara Falls, NY, April 14, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT imaging systems and clinical services, is pleased to …

Houston Patent Agent Offers Nonprovisional Patent Filing Services for Startups

Houston Patent Agent Offers Nonprovisional Patent Filing Services for Startups

Affordable Patent Agency expands to Houston, offering flat-fee nonprovisional patent filing services with expert support from a registered patent agent. HOUSTON, TX, UNITED STATES, April 14, 2025 /⁨EINPresswire.com⁩/ -- Affordable Patent Agency is excited …

Milwaukee's Underserved Communities Benefit from Outreach Community Health Center’s Use of the CHESS Health Platform

Milwaukee's Underserved Communities Benefit from Outreach Community Health Center’s Use of the CHESS Health Platform

Rochester, New York, April 14, 2025 (GLOBE NEWSWIRE) -- CHESS Health proudly announces a partnership with Outreach Community Health Centers (OCHC), a Federally Qualified Health Center (FQHC) based in Milwaukee, Wisconsin. This partnership is particularly …

Free Oral Cancer Screenings in Honor of Oral, Head and Neck Cancer Awareness Month

Free Oral Cancer Screenings in Honor of Oral, Head and Neck Cancer Awareness Month

IRVING, Texas, April 14, 2025 (GLOBE NEWSWIRE) -- In honor of Oral, Head and Neck Cancer Awareness Month, 26 U.S. Oral Surgery Management surgeon partners in seven states will offer free oral cancer screenings during the week of April 14. The screenings …

VIVUS Announces Enrollment of First Patient in Phase 2 Clinical Trial Assessing Ethanol-Free Carmustine as a Component of High-Dose Chemotherapy Prior to Transplant in Patients with Hodgkin or Non-Hodgkin Lymphoma

VIVUS Announces Enrollment of First Patient in Phase 2 Clinical Trial Assessing Ethanol-Free Carmustine as a Component of High-Dose Chemotherapy Prior to Transplant in Patients with Hodgkin or Non-Hodgkin Lymphoma

— Innovative ethanol-free formulation intended to provide improved safety and advance care for patients undergoing high-dose conditioning therapy prior to autologous hematopoietic cell transplantation (AHCT) — First patient dosed at City of Hope National …

NeuroOne® OneRF® Technology Success Story Featured on Fox News

NeuroOne® OneRF® Technology Success Story Featured on Fox News

Pediatric Patient Treated with OneRF® Ablation System Goes From Up to 10 Nightly Seizures to Zero EDEN PRAIRIE, Minn., April 14, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical …

Regional Health Properties Reports Fourth Quarter & Full Year 2024 Financial Results

Regional Health Properties Reports Fourth Quarter & Full Year 2024 Financial Results

ATLANTA, GA, April 14, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (the “Company”, “Regional”, “we”, “us” or “our”) (OTCQB: RHEP) (OTCQB: RHEPB) (OTCQB: RHEPA), a self-managed healthcare real estate investment company that invests primarily …

Verano Announces Promotion and Appointment of Richard Tarapchak as Chief Financial Officer

Verano Announces Promotion and Appointment of Richard Tarapchak as Chief Financial Officer

Tarapchak brings more than 30 years of accounting and finance expertise to the role CHICAGO, April 14, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today …

UPDATE -- Relmada Therapeutics To Present NDV-01 Data at AUA2025

UPDATE -- Relmada Therapeutics To Present NDV-01 Data at AUA2025

CORAL GABLES, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”, “the Company”), a clinical-stage biotechnology company, today announced the presentation of an abstract at the American Urology Association (AUA2025 …

Clene to Present at the Emerging Growth Conference

Clene to Present at the Emerging Growth Conference

SALT LAKE CITY, April 14, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company dedicated to advancing therapies for …

Can-Fite to Generate $685M in Projected Future Revenues from its Partnerships

Can-Fite to Generate $685M in Projected Future Revenues from its Partnerships

Ramat Gan, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs for oncological and inflammatory diseases, today announced …

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing

RADNOR, Pa., April 14, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of its Non-Animal Navigator™ solution designed to help biopharmaceutical companies lead the …

NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September

NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September

-- Trial Read-Out Data Expected in Early 2026 -- CALABASAS, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous system …

Longevity Health Holdings Announces Execution of Merger Agreement With 20/20 Biolabs

Longevity Health Holdings Announces Execution of Merger Agreement With 20/20 Biolabs

PITTSBURGH, Pa. …

Can-Fite Reports 2024 Financial Results and Clinical Update

Can-Fite Reports 2024 Financial Results and Clinical Update

RAMAT GAN, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service